$ Value
$37K
Shares
6,796
Price
$5
Filed
Jul 17
Insider
Name
Eisner Mark
Title
EVP and Chief Medical Officer
CIK
0001834161
Roles
Transaction Details
Transaction Date
2025-07-15
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
108,204
Footnotes
Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. | Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.41 to $5.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Filing Info
Eisner Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-25 | VIR | ▼ | $19K |
| 2026-02-24 | VIR | ▼ | $15K |
| 2026-02-23 | VIR | ▼ | $16K |
| 2026-02-22 | VIR | A | $0 |
| 2026-02-22 | VIR | A | $0 |
| 2026-02-21 | ZURA | A | $0 |
| 2025-07-17 | VIR | ▼ | $20K |
| 2025-07-15 | VIR | ▼ | $37K |
Other Insiders at VIR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SATO VICKI L | — | $992K | 2026-04-01 |
|
De Backer Marianne
Chief Executive Officer
|
— | $283K | 2026-02-24 |
|
De Backer Marianne
President and CEO
|
— | $664K | 2026-04-06 |
|
Eisner Mark
EVP and Chief Medical Officer
|
— | $50K | 2026-02-25 |
|
O'Byrne Jason
EVP & Chief Financial Officer
|
— | $31K | 2026-02-24 |
|
de Verneuil Vanina
EVP, General Counsel, Corp Sec
|
— | $197K | 2026-02-25 |
|
Sabatini Brent
SVP, Chief Accounting Officer
|
— | $110K | 2026-03-23 |